Product name:
(8S-cis)-10-[(3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride
Group:
Biochemicals
CAS Number:
25316-40-9
EC Number:
246-818-3
Synonyms:
fi6804, Doxorubicin (Adriamycin), Doxorubicin Hydrochloride, Lipodox, Doxorubicin (hydrochloride), DOX,Hydroxydaunorubicin hydrochloride, FI 106, Adriamycin, hydrochloride, CAELYX, Hydroxydaunorubicin hydrochloride, Dox hydrochloride, ADRIACIN, Doxorubicin (Adriamycin) HCl, Ardriamycin, Caely, 14-hydroxydaunomycin hydrochloride, adriamycin hydrochloride, Doxorubicin HCl, DOX, ADR, DOX HCl
Ipuac Name:
(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride
Molecular Formula:
C27H30ClNO11
Molecular Weight:
579.98 g/mol
Boiling Point:
810.3ºC at 760 mmHg
Flash Point:
443.8ºC
Melting Point:
216ºC
HS Code:
2941909000
Risk Statements:
R45; R22
Hazard Declaration:
H302; H315; H319; H350
Caution Statement:
P201; P305 + P351 + P338; P308 + P313
Signal World:
Danger